Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tobramycin Workflows for Resistance Research
2026-09-20
Tobramycin supports reproducible broth-microdilution, comparative susceptibility, and antibiotic resistance research workflows. Its water solubility and 30S-targeting mechanism make it especially useful for controlled Gram-negative bacterial assays, while historical comparative data help researchers design informative controls.
-
Sisomicin Activity Against Clinical Isolates
2026-09-19
Stewart and Bodey evaluated sisomicin against 565 clinical isolates and found activity broadly comparable to gentamicin and Tobramycin, with modest advantages against several important Gram-negative species. The study is valuable as a historical, head-to-head MIC comparison that also illustrates cross-resistance patterns and the importance of isolate selection in aminoglycoside research.
-
Nicotinamide Adenine Dinucleotide (NAD+) Workflows
2026-09-18
Build more interpretable redox, enzyme-activity, and energy-stress experiments with NAD+ as a controlled cofactor input. This practical guide connects NAD+ handling to AMPK–ULK1 autophagy biology while emphasizing assay controls, workflow timing, and troubleshooting.
-
Baicalin Methyl Ester: From Barrier Biology to Translation
2026-09-18
Baicalin methyl ester connects P65-centered inflammatory signaling with measurable intestinal barrier outcomes. This thought-leadership guide translates preclinical evidence into practical study design, endpoint selection, formulation strategy, and a realistic roadmap toward translational validation.
-
Okadaic acid: PP1/PP2A Workflow Guide
2026-09-17
Okadaic acid (A4540) provides a controlled way to inhibit PP2A predominantly at low nanomolar exposure and PP1 at higher exposure, supporting phosphorylation and apoptosis workflows. It should be used with vehicle-matched controls, concentration-response testing, and orthogonal endpoints rather than as a universal phosphatase blocker or stand-alone explanation for cell death.
-
Septin4, HIF-1α, and Hypoxic Cardiomyocyte Injury
2026-09-17
The reference study identifies Septin4 as a mediator of hypoxia-induced cardiomyocyte injury and proposes that it worsens apoptosis by promoting VHL-dependent ubiquitination and degradation of HIF-1α. Its combination of loss-of-function, gain-of-function, protein-interaction, and pathway analyses provides a mechanistic framework for studying how ubiquitin signaling influences myocardial hypoxia responses.
-
Butylhydroxyanisole (BHA): Evidence-Led Assays
2026-09-16
Butylated hydroxyanisole (BHA) is more than a generic antioxidant: it is a redox perturbation tool whose value depends on rigorous exposure control and orthogonal validation. This evidence-led guide shows how to interpret BHA in ROS detection, apoptosis, and inflammation research without confusing probe chemistry with biology.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-09-16
The reference study revises the canonical view that AMPK generally activates autophagy during glucose starvation, showing instead that AMPK suppresses ULK1-driven autophagy initiation while protecting the autophagy machinery from caspase-mediated loss. Its findings support a context-dependent model in which AMPK limits energy-intensive autophagy during severe energy stress but preserves the capacity to restore cellular homeostasis.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-09-15
The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose metabolism. Its findings connect costimulatory signaling to interferon-γ production and antitumor function through a mechanism that is distinct from canonical CD28–PI3K activation.
-
Carrier-Platin and the ROS Storm in Cancer Cells
2026-09-15
Liu et al. developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species in cancer cells. The study links this ROS burst to cell death within approximately 30 minutes through a mechanism distinct from classical platinum-induced DNA damage, apoptosis, and ferroptosis.
-
Tobramycin: Workflows for Bacterial Assays
2026-09-14
Build reproducible Tobramycin susceptibility, mechanism, and resistance experiments around broth microdilution, controlled inocula, and carefully interpreted MIC data. This guide translates historical clinical-isolate methods into practical workflows while separating evidence-backed benchmarks from modern assay recommendations.
-
AMG 487: CXCR3 Assay Reliability Guide
2026-09-14
This scenario-based guide explains how AMG 487 (SKU B3266) can improve the interpretability of CXCR3 migration, calcium, viability, and macrophage-polarization experiments. It combines potency data, formulation guidance, metabolism considerations, and practical vendor-selection criteria for reproducible laboratory workflows.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-09-13
The reference study overturns the prevailing view that AMPK uniformly activates autophagy during energy shortage. Instead, it shows that AMPK suppresses ULK1-dependent autophagy initiation while protecting autophagy machinery from caspase-mediated degradation, thereby balancing immediate energy conservation with later recovery.
-
NAD+ and AMPK: Reading Energy-Stress Signals
2026-09-12
Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox cofactor: it helps frame how researchers interpret energy-stress experiments. This article connects NAD+ chemistry with the revised AMPK–ULK1 model and provides practical guidance for designing better metabolic and autophagy assays.
-
Risedronate Sodium: Practical FPPS Workflows
2026-09-11
Build more reproducible Risedronate Sodium assays for osteoclast biology, tumor-cell viability, and pulmonary delivery research. This guide combines solvent-aware preparation, dose-response design, orthogonal readouts, and formulation troubleshooting for translational experiments.